Effect of chitobiose and chitotriose on carbon tetrachloride-induced acute hepatotoxicity in rats

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 10, 2005, Pages 1971-1973

  Chen, An Shu ^a   Taguchi, Tadao ^a   Sakai, Kazuo ^b   Matahira, Yoshiharu ^b   Wang, Min Wei ^c   Miwa, Ichitomo ^a  

^a MEIJO UNIVERSITY   (Japan)

^b Yaizu Suisan Kagaku Industry Co   (Japan)

^c SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Antioxidant activity; Carbon tetrachloride; Chitobiose; Chitotriose; Hepatotoxicity

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKENE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CARBON TETRACHLORIDE; CHITOBIOSE; CHITOSAN DERIVATIVE; CHITOTRIOSE; MALONALDEHYDE; OLIGOSACCHARIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; LIPID PEROXIDATION; LIVER INJURY; LIVER PROTECTION; LIVER TOXICITY; MALE; NONHUMAN; RAT;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CARBON TETRACHLORIDE POISONING; DISACCHARIDES; LIVER; MALE; RATS; RATS, WISTAR; TRISACCHARIDES;

EID: 26444546753     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.28.1971     Document Type: Article

References (15)

1. Hirano S., Nagao N., Agric. Biol. Chem., 53, 3065-3066 (1989).
2. Choi B.-K., Kim K.-Y., Yoo Y.-J., Oh S.-J., Choi J.-H., Kim C.-Y., Int. J. Antimicrobi. Agents, 18, 553-557 (2001).
3. Kendra D. F., Hadwiger L. A., Exp. Mycol., 8, 276-281 (1984).
4. Xue C., Yu G., Hirata T., Terao J., Lin H., Biosci. Biotechnol. Biochem., 62, 206-209 (1998).
5. Nam K.-S., Choi Y.-R., Shon Y.-H., Biotechnol. Lett., 23, 971-975 (2001).
6. Pae H.-O., Seo W.-G., Kim N.-Y., Oh G.-S., Kim G.-E., Kim Y.-H., Kwak H.-J., Yun Y.-G., Jun C.-D., Chung H.-T., Leuk. Res., 25, 339-346 (2001).
7. Chen A.-S., Taguchi T., Sakai K., Kikuchi K., Wang M.-W., Miwa I., Biol. Pharm. Bull., 26, 1326-1330 (2003).
8. Chen A.-S., Taguchi T., Okamoto H., Danjo K., Sakai K., Matahira Y., Wang M.-W., Miwa I., Biol. Pharm. Bull., 28, 545-548 (2005).
9. Recknagel R. O., Glende E. A., Jr., Dolak J. A., Waller R. L., Pharmacol. Ther., 43, 139-154 (1989).
10. Sheweita S. A., Abd El-Gabar M., Bastawy M., Toxicology, 165, 217-224 (2001).
11. Sotelo-Félix J. I., Martinez-Fong D., Muriel P., Santillan R. L., Castillo D., Yahuaca P., J. Ethnopharmacol., 81, 145-154 (2002).
12. Ritter C., Reinke A., Andrades M., Martins M. R., Rocha J., Menna-Barreto S., Quevedo J., Moreira J. C. F., Dal-Pizzol F., Crit. Care Med., 32, 2079-2084 (2004).
13. Aniya Y., Koyama T., Miyagi C., Miyahira M., Inomata C., Kinoshita S., Ichiba T., Biol. Pharm. Bull., 28, 19-23 (2005).
14. Jeon T. I., Hwang S. G., Park N. G., Jung Y. R., Shin S. I., Choi S. D., Park D. K., Toxicology, 187, 67-73 (2003).
15. Shon Y.-H., Park I.-K., Moon I.-S., Chang H. W., Park I.-K., Nam K.-S., Biol. Pharm. Bull., 25, 1161-1164 (2002).